Stay updated on Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Sign up to get notified when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history list. This update affects only the revision history entries on the page and does not alter study data or functionality.
    Difference
    0.1%
    Check dated 2026-03-12T02:20:15.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Addition of Revision: v3.4.2 and the removal of the funding/operating status notice are site-wide administrative updates. They do not change the study record, its data, or the core content of the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.6%
    Check dated 2026-02-11T14:07:08.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    Added a government funding status notice and updated the page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.6%
    Check dated 2026-02-04T10:18:01.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    New glossary toggle, color-coded diff highlights (green for additions, red for deletions), and a revised revision label (v3.4.0) were added, while the previous revision (v3.3.4) and the 'No FEAR Act Data' text were removed.
    Difference
    0.8%
    Check dated 2026-01-28T05:59:31.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    Added a new Revision: v3.3.4 entry and removed the previous Revision: v3.3.3 entry in the version history. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T01:55:59.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    A new Revision: v3.3.3 entry was added, and the HHS Vulnerability Disclosure link along with Revision: v3.3.2 were removed from the footer/history.
    Difference
    0.2%
    Check dated 2025-12-23T09:20:58.000Z thumbnail image

Stay in the know with updates to Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tirzepatide in Type 2 Diabetes: SURPASS-1 Clinical Trial page.